Article

Activation of TGR5 Partially Alleviates High Glucose-Induced Cardiomyocyte Injury by…

Oxidative Medicine and Cellular Longevity · 2019 · Li Deng, author Xuxin Chen, author Yi Zhong, author Xing Wen, author Ying Cai, author Jiafu Li, author Zhongcai Fan, author Jian Feng, author Adrian Doroszko, Guest Editor

Key facts

Title Activation of TGR5 Partially Alleviates High Glucose-Induced Cardiomyocyte Injury by Inhibition of Inflammatory Responses and Oxidative Stress
First author Li Deng, author Xuxin Chen, author Yi Zhong, author Xing Wen, author Ying Cai, author Jiafu Li, author Zhongcai Fan, author Jian Feng, author Adrian Doroszko, Guest Editor
Journal Oxidative Medicine and Cellular Longevity
Published Apr 12, 2019
DOI 10.1155/2019/6372786
Devices mentioned K973350, K990827
Product codes mentioned JLX, KQP

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature